Continuum Advisory, LLC Inmune Bio, Inc. Transaction History
Continuum Advisory, LLC
- $778 Million
- Q3 2024
A detailed history of Continuum Advisory, LLC transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Continuum Advisory, LLC holds 1,000 shares of INMB stock, worth $4,960. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,000
Previous 1,000
-0.0%
Holding current value
$4,960
Previous $8,000
37.5%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding INMB
# of Institutions
70Shares Held
5.88MCall Options Held
243KPut Options Held
46.4K-
Black Rock Inc. New York, NY813KShares$4.03 Million0.0% of portfolio
-
Praetorian Pr LLC Rincon, PR781KShares$3.87 Million1.64% of portfolio
-
Vanguard Group Inc Valley Forge, PA721KShares$3.57 Million0.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE596KShares$2.96 Million45.87% of portfolio
-
Raymond James Financial Services Advisors, Inc. St. Petersburg, FL369KShares$1.83 Million0.0% of portfolio
About Inmune Bio, Inc.
- Ticker INMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,946,000
- Market Cap $89M
- Description
- INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...